Tuesday, June 15, 2021 9:47:14 PM
I imagine that Medtronic or any big medtech company (JNJ, Stryker, etc) would ALL WANT TO BE INVOLVED in the regulatory and clinical process. There is too much valuable data that comes from any clinical trial that can be collected and utilized in the commercialization of the product. To think they wouldn't want oversight is niave.
That's why in this robotic space, these companies, like Titan, will be "accounted" for before they are put in human clinical trials. If they don't get accounted for, like a TRXC, then its just a long uphill battle with no upside to investors b/c they don't have technology that is worth premium dollars from the big medtech players.
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM